NCT04005690 2026-02-27Targeted Pathway Inhibition in Patients With Pancreatic CancerOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Recruiting90 enrolled
NCT02264678 2026-02-20Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsAstraZenecaPhase 1/2 Active not recruiting357 enrolled